Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Preoperative prediction of extracapsular extension (ECE) of prostate cancer (PCa) is important to guide clinical decision‐making and improve patient prognosis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To investigate the value of multiparametric magnetic resonance imaging (mpMRI)‐based peritumoral radiomics for preoperative prediction of the presence of ECE.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Retrospective.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Population</h3><p>Two hundred eighty‐four patients with PCa from two centers (center 1: 226 patients; center 2: 58 patients). Cases from center 1 were randomly divided into training (158 patients) and internal validation (68 patients) sets. Cases from center 2 were assigned to the external validation set.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength/Sequence</h3><p>A 3.0 T MRI scanners (three vendors). Sequence: Pelvic T2‐weighted turbo/fast spin echo sequence and diffusion weighted echo planar imaging sequence.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>The peritumoral region (PTR) was obtained by 3–12 mm (half of the tumor length) 3D dilatation of the intratumoral region (ITR). Single‐MRI radiomics signatures, mpMRI radiomics signatures, and integrated models, which combined clinical characteristics with the radiomics signatures were built. The discrimination ability was assessed by area under the receiver operating characteristic curve (AUC) in the internal and external validation sets.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>Fisher's exact test, Mann–Whitney U‐test, DeLong test.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The PTR radiomics signatures demonstrated significantly better performance than the corresponding ITR radiomics signatures (AUC: 0.674 vs. 0.554, <i>P</i> < 0.05 on T2‐weighted, 0.652 vs. 0.546, <i>P</i> < 0.05 on apparent diffusion coefficient, 0.682 vs. 0.556 on mpMRI in the external validation set). The integrated models combining the PTR radiomics signature with clinical characteristics performed better than corresponding radiomics signatures in the internal validation set (eg. AUC: 0.718 vs. 0.671, <i>P</i> < 0.05 on mpMRI) but performed similar in the external validation set (eg. AUC: 0.684, vs. 0.682, <i>P</i> = 0.45 on mpMRI). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>The peritumoral radiomics can better predict the presence of ECE preoperatively compared with the intratumoral radiomics and may have better generalization than clinical characteristics.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Evidence Level</h3><p>4</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy</h3><p>2</p></section>

Defining the role of multiparametric MRI in predicting prostate cancer extracapsular extension

The value of multiparametric MRI for predicting prostate cancer extracapsular extension

Can 3D Multiparametric Ultrasound Imaging Predict Prostate Biopsy Outcome?

PREDICTION OF PROSTATE BIOPSY OUTCOME BY MULTIPARAMETRIC ULTRASOUND IMAGING

The Role of Multiparametric MRI (mpMRI) in the Prediction of Adverse Prostate Cancer Pathology in Radical Prostatectomy Specimen

Multiparametric Magnetic Resonance Imaging‐Based Peritumoral Radiomics for Preoperative Prediction of the Presence of Extracapsular Extension With Prostate Cancer

Extra-prostatic extension (EPE) grading system: Correlation with MRI features and integration of capsular enhancement sign (CES) for “enhanced” detection of T3a lesions

MRI-Based Radiomics Signature for the Preoperative Prediction of Extracapsular Extension of Prostate Cancer.

Development and comparison of a Chinese nomogram adding multi-parametric MRI information for predicting extracapsular extension of prostate cancer.

Association of multiparametric magnetic resonance imaging findings with oncologic outcomes in non-palpable localized prostate cancer.

Prediction of extracapsular extension of prostate cancer by MRI radiomic signature: a systematic review

External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension

Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation study

Bicenter validation of a risk model for the preoperative prediction of extraprostatic extension of localized prostate cancer combining clinical and multiparametric MRI parameters

Preoperative Prediction of Extracapsular Extension: Radiomics Signature Based on Magnetic Resonance Imaging to Stage Prostate Cancer

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm

MRI-based nomograms and radiomics in presurgical prediction of extraprostatic extension in prostate cancer: a systematic review

An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy

Effect of MRI in the Evaluation of Extra-Capsular Extension of Prostate Cancer

Prediction of Extraprostatic Extension in Patients with Clinically Organ-Confined Prostate Cancer.

Added Value of Biparametric MRI and TRUS-Guided Systematic Biopsies to Clinical Parameters in Predicting Adverse Pathology in Prostate Cancer